Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants

NCT00697125 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

BIOLOGICAL: Engerix™-B
BIOLOGICAL: HBV-MPL vaccine (208129)
BIOLOGICAL: Hepatitis B vaccine, experimental formulation

Sponsor

GlaxoSmithKline